Yilmaz, M., Muftuoglu, M., DiNardo, C. D., Kadia, T. M., Konopleva, M., Chan, O., Borthakur, G., Pemmaraju, N., Short, N. J., Valero, Y. A., Maiti, A., Masarova, L., Montalban-Bravo, G., Loghavi, S., Kornblau, S. M., Sallman, D. A., Jabbour, E., Ravandi-Kashani, F., Andreeff, M., Daver, N. G. (2026). Quizartinib in combination with decitabine and venetoclax for newly diagnosed and relapsed/refractory FLT3 -mutated AML.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6504